Cefapirin
{{Short description|Chemical compound}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 460022704
| IUPAC_name =
| image = Cefapirin.svg
| tradename =
| Drugs.com = {{drugs.com|international|cefapirin}}
| MedlinePlus = a601206
| pregnancy_AU =
| pregnancy_US = B
| pregnancy_category =
| legal_AU =
| legal_UK =
| legal_US = Rx-only
| legal_status =
| routes_of_administration = Intravenous, intramuscular
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 21593-23-7
| ATC_prefix = J01
| ATC_suffix = DB08
| ATC_supplemental = {{ATCvet|G51|AA05}} {{ATCvet|J51|DB08}}
| PubChem = 30699
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01139
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 28486
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 89B59H32VN
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07636
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 554446
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1599
| C=17 | H=17 | N=3 | O=6 | S=2
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)CSc3ccncc3)COC(=O)C)C(=O)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UQLLWWBDSUHNEB-CZUORRHYSA-N
}}
Cefapirin (INN, also spelled cephapirin) is an injectable, first-generation cephalosporin antibiotic. It is marketed under the trade name Cefadyl. Production for use in humans has been discontinued in the United States.{{cite web | title = CEFADYL | url = http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=CEFADYL | archive-url = https://web.archive.org/web/20060926002502/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=CEFADYL | url-status = dead | archive-date = September 26, 2006 | publisher = U.S. Food and Drug Administration }}
It also has a role in veterinary medicine as Metricure, an intrauterine preparation, and combined with prednisolone in Mastiplan, an intramammary preparation. Both are licensed in cattle.{{cn|date=March 2023}}
Synthesis
In one of the syntheses, 7-aminocephalosporanic acid (7-ACA) is reacted with bromoacetyl chloride to give the amide. The halo group is then displaced by 4-thiopyridine.